Statistical treatment of fluorescence in situ hybridization validation data to generate normal reference ranges using excel functions

Journal of Molecular Diagnostics

Volumn 11, Issue 4, 2009, Pages 330-333

  Ciolino, Allison L ^a   Tang, Mary E ^a,b   Bryant, Ron ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b FLETCHER ALLEN HEALTH CARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BINOMIAL DISTRIBUTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FLUORESCENCE IN SITU HYBRIDIZATION; STATISTICAL ANALYSIS; STATISTICS;

HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NORMAL DISTRIBUTION; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SOFTWARE;

EID: 69249117858     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2009.080101     Document Type: Article

References (14)

1. Ou J, Vergilio J, Bagg A: Molecular diagnosis and monitoring in the clinical management of patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors. Am J Hematol 2008, 83:296-302
2. Park IJ, AeLim Y, Lee WG, Park JS, Kim HC, Lee HJ, Cho SR: A case of chronic myelogenous leukemia with e8a2 fusion transcript. Cancer Genet Cytogenet 2008, 185:106-108
3. Dewald G, Stallard R, Alsaadi A, Arnold S, Blough R, Ceperich TM, Elejalde BR, Fink J, Higgins JV, Higgins RR, Hoeltge GA, Hsu WT, Johnson EB, Kronberger D, McCorquodale DJ, Meisner LF, Micale MA, Oseth L, Payne JS, Schwartz S, Sheldon S, Sophian A, Storto P, Tuinen PV, Wenger GD, Wiktor A, Willis LA, Yung JF, Zenger-Hain J: A multicenter investigation with D-FISH BCR/ABL1 probes. Cancer Genet Cytogenet 2000, 116:97-104
4. Wiktor AE, Van Dyke DL, Stupca PJ, Ketterling RP, Thorland EC, Shearer BM, Fink SR, Stockero KJ, Majorowicz JR, Dewald GW: Preclinical validation of fluorescence in situ hybridization assays for clinical practice. Genet Med 2006, 8:16-23
5. Thall P, Jacoby D, Zimmerman S: Estimating genomic category probablities from fluorescent in situ hybridization counts with misclassification. Appl Stat 1996, 45:431-446
6. American College of Medical Genetics Standards and Guidelines for Clinical Genetics Laboratories, 2006 edition. Section E10.3.1
7. McClatchey, KD: Clinical laboratory medicine, second edition. Edited by McClatchey KD. Philadelphia, Lippincott, Williams, & Wilkins, 2002, pp. 658-685
8. American College of Medical Genetics Standards and Guidelines for Clinical Genetics Laboratories, 2006 edition. Section E10.3.2
9. Landstrom AP and Tefferi A: Fluorescent in situ hybridization in the diagnosis, prognosis, and treatment monitoring of chronic myeloid leukemia. Leuk Lymph 2006, 47:397-402
10. Wolff DJ, Bagg A, Cooley LD, Dewald GW, Hirsch BA, Jacky PB, Rao KW, Rao PN, the Association for Molecular Pathology Clinical Practice Committee and the American College of Medical Genetics Laboratory Quality Assurance Committee: Guidance for fluorescence in situ hybridization testing in hematological disorders. J Mol Diagn 2007, 9:134-143
11. Papoulis, A: Probability, random variables, and stochastic processes, third edition. Edited by Howell RL and Morriss JM. New York, McGraw-Hill, 1991
12. Evans M, Hastings N, Peacock B: Statistical distributions, third edition. Edited by Evans M. New York, John Wiley and Sons, Inc., 2000, pp. 34-42
13. Simon J: The statistical functions, Chapter 15 in Excel 2000 in a Nutshell [internet]. O'Reilly Media, Inc., 2000, 404-473
14. Dewald G, Wyatt W, Juneau A, Carlson R, Zinsmeister A, Jalal S, Spurbeck J, Silver R: Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia. Blood 1998, 91:3357-3365